Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning.

McWhir J, Selfridge J, Harrison DJ, Squires S, Melton DW.

Nat Genet. 1993 Nov;5(3):217-24.

PMID:
8275084
2.
3.

Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence.

Weeda G, Donker I, de Wit J, Morreau H, Janssens R, Vissers CJ, Nigg A, van Steeg H, Bootsma D, Hoeijmakers JH.

Curr Biol. 1997 Jun 1;7(6):427-39.

4.

Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells.

Li Q, Yu JJ, Mu C, Yunmbam MK, Slavsky D, Cross CL, Bostick-Bruton F, Reed E.

Anticancer Res. 2000 Mar-Apr;20(2A):645-52.

PMID:
10810335
5.

Disruption of the mouse xeroderma pigmentosum group D DNA repair/basal transcription gene results in preimplantation lethality.

de Boer J, Donker I, de Wit J, Hoeijmakers JH, Weeda G.

Cancer Res. 1998 Jan 1;58(1):89-94.

6.

Characterization of premature liver polyploidy in DNA repair (Ercc1)-deficient mice.

Chipchase MD, O'Neill M, Melton DW.

Hepatology. 2003 Oct;38(4):958-66.

PMID:
14512883
7.

Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage.

Larminat F, Bohr VA.

Nucleic Acids Res. 1994 Aug 11;22(15):3005-10.

8.

Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination.

Melton DW, Ketchen AM, Núñez F, Bonatti-Abbondandolo S, Abbondandolo A, Squires S, Johnson RT.

J Cell Sci. 1998 Feb;111 ( Pt 3):395-404.

9.

Identical defects in DNA repair in xeroderma pigmentosum group G and rodent ERCC group 5.

O'Donovan A, Wood RD.

Nature. 1993 May 13;363(6425):185-8.

PMID:
8483505
11.

Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.

Fan R, Kumaravel TS, Jalali F, Marrano P, Squire JA, Bristow RG.

Cancer Res. 2004 Dec 1;64(23):8526-33.

12.

Correction of liver dysfunction in DNA repair-deficient mice with an ERCC1 transgene.

Selfridge J, Hsia KT, Redhead NJ, Melton DW.

Nucleic Acids Res. 2001 Nov 15;29(22):4541-50.

13.

Gene targeting using a mouse HPRT minigene/HPRT-deficient embryonic stem cell system: inactivation of the mouse ERCC-1 gene.

Selfridge J, Pow AM, McWhir J, Magin TM, Melton DW.

Somat Cell Mol Genet. 1992 Jul;18(4):325-36.

PMID:
1440055
15.
16.

Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition.

Friedberg EC, Bond JP, Burns DK, Cheo DL, Greenblatt MS, Meira LB, Nahari D, Reis AM.

Mutat Res. 2000 Mar 20;459(2):99-108. Review.

PMID:
10725660
17.

DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage.

Jimenez GS, Bryntesson F, Torres-Arzayus MI, Priestley A, Beeche M, Saito S, Sakaguchi K, Appella E, Jeggo PA, Taccioli GE, Wahl GM, Hubank M.

Nature. 1999 Jul 1;400(6739):81-3.

PMID:
10403253
18.

Tumor suppressor p53 dependent recruitment of nucleotide excision repair factors XPC and TFIIH to DNA damage.

Wang QE, Zhu Q, Wani MA, Wani G, Chen J, Wani AA.

DNA Repair (Amst). 2003 May 13;2(5):483-99.

PMID:
12713809
19.

Induction of a mutant phenotype in human repair proficient cells after overexpression of a mutated human DNA repair gene.

Belt PB, van Oosterwijk MF, Odijk H, Hoeijmakers JH, Backendorf C.

Nucleic Acids Res. 1991 Oct 25;19(20):5633-7.

20.

p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.

Hoogervorst EM, van Oostrom CT, Beems RB, van Benthem J, Gielis S, Vermeulen JP, Wester PW, Vos JG, de Vries A, van Steeg H.

Cancer Res. 2004 Aug 1;64(15):5118-26.

Supplemental Content

Support Center